Cargando…
Late-onset Pompe disease (LOPD) in Belgium: clinical characteristics and outcome measures
BACKGROUND: Late-onset Pompe disease (LOPD) is a rare, hereditary, progressive disorder that is usually characterized by limb-girdle muscle weakness and/or respiratory insufficiency. LOPD is caused by mutations in the acid alpha-glucosidase (GAA) gene and treated with enzyme replacement therapy (ERT...
Autores principales: | Vanherpe, P., Fieuws, S., D’Hondt, A., Bleyenheuft, C., Demaerel, P., De Bleecker, J., Van den Bergh, P., Baets, J., Remiche, G., Verhoeven, K., Delstanche, S., Toussaint, M., Buyse, B., Van Damme, P., Depuydt, C. E., Claeys, K. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133011/ https://www.ncbi.nlm.nih.gov/pubmed/32248831 http://dx.doi.org/10.1186/s13023-020-01353-4 |
Ejemplares similares
-
A retrospective survey of patients with hereditary transthyretin-mediated (hATTR) amyloidosis treated with patisiran in real-world clinical practice in Belgium
por: De Bleecker, Jan L., et al.
Publicado: (2023) -
Early is better? A new algorithm for early diagnosis in Late Onset Pompe Disease (LOPD)
por: TOSCANO, ANTONIO, et al.
Publicado: (2013) -
Distribution of Exonic Variants in Glycogen Synthesis and Catabolism Genes in Late Onset Pompe Disease (LOPD)
por: De Filippi, Paola, et al.
Publicado: (2023) -
Six-Minute Walk Distance Is a Useful Outcome Measure to Detect Motor Decline in Treated Late-Onset Pompe Disease Patients
por: Claeys, Kristl G., et al.
Publicado: (2022) -
Vacuolated PAS-Positive Lymphocytes on Blood Smear: An Easy Screening Tool and a Possible Biomarker for Monitoring Therapeutic Responses in Late Onset Pompe Disease (LOPD)
por: Parisi, Daniela, et al.
Publicado: (2018)